Loading Events

Go Back

event image

Expert Forum on Multiple Myeloma – Dallas, TX

August 23 - 24, 2019


Coming soon…

Download our Brochure


  • Review the current genomic landscape of multiple myeloma, clinical features of poor prognosis, mechanisms of resistance, immune signatures, and the integration of MRD into clinical trials
  • Examine the evolving role of transplantation and cellular therapy for the treatment of multiple myeloma, including CAR-T, ASCT, and allogeneic SCT
  • Evaluate key aspects of supportive care and complications, including bone disease, as well as definitions of disease, especially SMM/MGUS
  • Debate proteasome inhibitors, how to tailor treatment to patient populations, and broader strategies to overcome proteasome inhibitor resistance
  • Consider the benefits and challenges of long term lenalidomide therapy, as well as the emerging role of next generation IMiDs and Cell Mods
  • Discuss the integration of novel therapies and MoAbs in particular, including SLAMF7, CD 38, CAR-T cell therapy and targeting BCL2, as well as vaccines, and other novel targets, including nuclear export proteins and peptidase-avid alkylation
  • Understand the continued potential of targeting BCMA both in the setting of CAR-T therapy and MoAbs/ADC’s